On March 27, 2024, Ayala Pharmaceuticals, Inc. and Roy Golan, Chief Financial Officer, agreed that Mr. Golan would depart the Company on June 25, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 USD | +36.36% | +42.86% | -55.02% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.02% | 9.38M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Ayala Pharmaceuticals, Inc. Announces Departure of Roy Golan as Chief Financial Officer, Effective from June 25, 2024